| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $3.4B | $3.8B | $3.7B | $3.6B | $3.5B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B |
| Operating Income | $0.3B | $0.5B | — | — | — |
| Net Income | $0.1B | $0.3B | $0.3B | $0.1B | $0.3B |
| EPS (Basic) | $3.29 | $7.35 | $6.02 | $2.68 | $7.53 |
| EPS (Diluted) | $3.24 | $7.18 | $5.93 | $2.66 | $7.53 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $2.8B | $2.6B | $2.9B | $2.7B | $2.6B |
| Current Assets | $1.1B | $1.1B | $1.2B | $1.2B | $1.1B |
| Cash & Equivalents | — | — | — | — | — |
| Total Liabilities | — | — | — | — | — |
| Current Liabilities | $0.7B | $0.7B | $0.7B | $0.7B | $0.8B |
| Stockholders' Equity | $1.0B | $0.8B | $0.9B | $0.7B | $0.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.5B | $0.5B | $0.4B | $0.5B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.4B | $0.2B | $0.1B |
| Capital Expenditures | — | — | — | $0.1B | $0.1B |
| Financing Cash Flow | $-0.1B | $-0.3B | $-0.2B | $-0.5B | $-0.6B |